Clinical trial of calcium polystyrene sulfonate for the treatment of hyperkalemia in patients on hemodialysis
- 作者: Shutov Y.V1,2, Kotlyarova G.V1, Lysenko K.M1, Fedorov D.V1
-
隶属关系:
- SBHCI "City Clinical Hospital n.a. S.P. Botkin of the Moscow Healthcare Department”
- FSBEI FPE "Russian Medical Academy of Continuous Professional Education" of the Ministry of Health of the Russian Federation
- 期: 编号 1 (2019)
- 页面: 22-27
- 栏目: Articles
- URL: https://journals.eco-vector.com/2075-3594/article/view/273170
- DOI: https://doi.org/10.18565/nephrology.2019.1.22-27
- ID: 273170
如何引用文章
详细
全文:
作者简介
Ye. Shutov
SBHCI "City Clinical Hospital n.a. S.P. Botkin of the Moscow Healthcare Department”; FSBEI FPE "Russian Medical Academy of Continuous Professional Education" of the Ministry of Health of the Russian Federation
Email: shutov_e_v@mail.ru
Doctor of Medical Sciences, Head of the Department of Nephrology № 12; Professor at the Department of Nephrology and Hemodialysis Moscow, Russia
G. Kotlyarova
SBHCI "City Clinical Hospital n.a. S.P. Botkin of the Moscow Healthcare Department”PhD in Medical Science, nephrologist at the department of Nephrology № 12 Moscow, Russia
K. Lysenko
SBHCI "City Clinical Hospital n.a. S.P. Botkin of the Moscow Healthcare Department”Nephrologist at the department of Nephrology № 12 Moscow, Russia
D. Fedorov
SBHCI "City Clinical Hospital n.a. S.P. Botkin of the Moscow Healthcare Department”Nephrologist at the department of Nephrology № 12 Moscow, Russia
参考
- Mushiyakh Y., Dangaria H., Qavi S. Treatment and pathogenesis of acute hyperkalemia. J. Community Hosp. Intern. Med. Perspect. 2011; 1(4).
- Lehnhardt A, Kemper M.J. Pathogenesis, diagnosis and management of hyperkalemia. Pediatr. Nephrol. 2011; 26: 377-384.
- Crawford A.H. Hyperkalemia: recognition and management of a critical electrolyte disturbance. J. Infus. Nurs. 2014; 37: 167-175. doi: 10.1097/NAN.0000000000000036.
- Jain N., Kotla S., Little B.B. Predictors of hyperkalemia and death in patients with cardiac and renal disease. Am. J. Cardiol. 2012; 109: 1510-1513. doi: 10.1016/j.amjcard.2012.01.367.
- McMahon G.M., Mendu M.L., Gibbons F.K., Christopher K.B. Association between hyperkalemia at critical care initiation and mortality. Intensive Care Med. 2012; 38: 1834-1842. doi: 10.1007/s00134-012-2636-7.
- Allon M. Hyperkalemia in end-stage renal disease: mechanisms and management. J. Am. Soc. Nephrol. 1995; 6: 1134-1142.
- Acker C.G., Johnson J.P., Palevsky P.M., Greenberg A. Hyperkalemia in hospitalized patients: causes, adequacy of treatment, and results of an attempt to improve physician compliance with published therapy guidelines. Arch. Intern. Med. 1998; 158: 917-924.
- Khanagavi J., Gupta T., Aronow W.S. Hyperkalemia among hospitalized patients and association between duration of hyperkalemia and outcomes. Arch. Med. Sci. 2014; 10: 251-257. doi: 10.5114/aoms.2014.42577.
- Noize P., Bagheri H., Durrieu G. Life-threatening drug-associated hyperkalemia: a retrospective study from laboratory signals. Pharma Coepidemiol. Drug Saf. 2011; 20: 747-753. doi: 10.1002/pds.2128.
- Nyirenda M.J., Tang J.I., Padfield PL., Seckl J.R. Hyperkalaemia. BMJ. 2009; 339: b4114.
- Einhorn L.M., Zhan M., Hsu V.D. The frequency of hyperkalemia and its significance in chronic kidney disease. Arch. Intern. Med. 2009; 169: 1156-1162. doi: 10.1001/archinternmed.2009.132.
- Hayes J., Kalantar-Zadeh K., Lu J.L. Association of hypo- and hyperkalemia with disease progression and mortality in males with chronic kidney disease: the role of race. Nephron Clin. Pract. 2012; 120: c8-c16. doi: 10.1159/000329511.
- Kovesdy C.P, Regidor D.L., Mehrotra R. Serum and dialysate potassium concentrations and survival in hemodialysis patients. Clin. J. Am. Soc. Nephrol. 2007; 2: 999-1007.
- Pitt B., Collins A.J., Reaven N. Effect of cardiovascular comorbidities on the mortality risk associated with serum potassium. Circulation. 2014; 130(2): A13320-A13320.
- Torlen K., Kalantar-Zadeh K., Molnar M.Z. Serum potassium and cause-specific mortality in a large peritoneal dialysis cohort. Clin. J. Am. Soc. Nephrol. 2012; 7: 1272-1284. doi: 10.2215/CJN.00960112.
- Rastegar A., Soleimani M. Hypokalaemia and hyperkalaemia. Postgrad. Med. J. 2001 Dec; 77(914): 759-64. Erratum in: Postgrad. Med. J. 2002; 78(916): 126.
- Kovesdy C.P. Management of hyperkalaemia in chronic kidney disease. Nat. Rev. Nephrol. 2014; 10(11): 653-662. doi: 10.1038/nrneph.2014.168.
- Weiner I.D., Wingo C.S. Hyperkalemia: a potential silent killer. J. Am. Soc. Nephrol. 1998; 9(8): 1535-1543.
- Hollander-Rodriguez J.C., Calvert J.F. Jr. Hyperkalemia. Am. Fam. Physician. 2006; 73(2): 283-290.
- Widimisky P. Hypokalemia and the heart. E-J. Cardiol. Pract. 2008; 7: 9-12.
- An J.N., Lee J.P., Jeon H.J., Kim H., Oh Y.K., Kim Y.S., Lim C.S. Severe hyperkalemia requiring hospitalization: predictors of mortality. Crit. Care. 2012; 16: R225. doi: 10.1186/cc11872.
- Herzog C.A., Mangrum J.M., Passman R. Sudden cardiac death and dialysis patients. Semin. Dial. 2008; 21(4): 300-307.
- Foley R.N., Gilbertson D.T., Murray T., Collins A.J. Long interdialytic interval and mortality among patients receiving hemodialysis. N. Engl. J. Med. 2011; 365(12): 1099-1107. doi: 10.1056/NEJMoa1103313.
- Bleyer A.J., Hartman J., Brannon P.C., Reeves-Daniel A., Satko S.G., Russell G. Characteristics of sudden death in hemodialysis patients. Kidney Int. 2006; 69(12): 2268-2273.
- Perazella M.A., Mahnensmith R.L. Hyperkalemia in the elderly: drugs exacerbate impaired potassium homeostasis. J. Gen. Intern. Med. 1997; 12(10): 646-656.
- Sonal Korgaonkar, Anca Tilea, Brenda W., et al. Serum Potassium and Outcomes in CKD: Insights from the RRI-CKD Cohort Study Clin. J. Am. Soc. Nephrol. 2010; 5(5): 762-769.
- Sacchetti A., Stuccio N., Panebianco P., Torres M., et al. ED hemodialysis for treatment of renal failure emergencies. Am. J. Emerg. Med.1999; 17(3): 305-307.
- Lepage L., Dufour A.C., Doiron J., et al. Randomized clinical trial of sodium polystyrene sulfonate for the treatment of mild hyperkalemia in CKD. Clin. J. Am. Soc. Nephrol. 2015; 10: 2136-2142.
- Nasir K., Ahmad A. Treatment of hyperkalemia in patients with chronic kidney disease: A comparison of calcium polystyrene sulphonate and sodium polystyrene sulphonate. J. Ayub. Med. College, Abbottabad: JAMC. 2014; 26: 455-458.
- Gruy Kapral C., Emmett M., Santa Ana C.A., Porter J.L., Fordtran J.S., Fine K.D. Effect of single dose resin cathartic therapy on serum potassium concentration in patients with end stage renal disease. J. Am. Soc. Nephrol. 1998; 9: 1924-1930.
- Sterns R.H., Rojas M., Bernstein P., Chennupati S. Ion Exchange resins for the treatment of hyperkalemia: Are they safe and effective? J. Am. Soc. Nephrol. 2010; 21: 733-735.
- Scherr L., Ogden D.A., Mead A.W., Spritz N., Rubin A.L. Management of hyperkalemia with a cation exchange resin. N. Engl. J.Med. 1961; 264: 115-119.
- Noureddine L., Dixon B.S. Complications and management of hyperkalemia: Implications for the use of the novel cation exchangers zirconium cyclosilicate and patiromer. Clin. Invest. 2015; 5: 805-823.
- Betts K.A., Woolley J.M., Fan Mu, et al. The cost of hyperkalemia in the United States Kidney Int. Rep. 2018; 3(2): 385-393. doi: 10.1080/03007995.2018.1433141.